Showing results (2501-2510 of 2,509) with videos related to

Sort By:
Pageof 251
You have reached the last page of results.This site can display upto 2,509 results.
The Journal of Infection|November 9, 2024
Real-world effectiveness and safety of simnotrelvir/ritonavir for COVID-19: A nationwide, multicenter, prospective, observational cohort study in ChinaBing Han, Chunling Du, Min Deng, et al.
NEJM Evidence|May 28, 2024
Olgotrelvir as a Single-Agent Treatment of Nonhospitalized Patients with Covid-19Rongmeng Jiang, Bing Han, Wanhong Xu, et al.
Medical Image Analysis|January 5, 2025
SegRap2023: A benchmark of organs-at-risk and gross tumor volume Segmentation for Radiotherapy Planning of Nasopharyngeal CarcinomaXiangde Luo, Jia Fu, Yunxin Zhong, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|May 20, 2015
Establishing a Nomogram for Stage IA-IIB Cervical Cancer Patients after Complete ResectionHang Zhou, Xiong Li, Yuan Zhang, et al.
JAMA Network Open|May 4, 2019
Assessment of Molecular Subtypes in Thyrotoxic Periodic Paralysis and Graves Disease Among Chinese Han Adults: A Population-Based Genome-Wide Association StudyShuang-Xia Zhao, Wei Liu, Jun Liang, et al.
The New England Journal of Medicine|March 13, 2024
Oral Iptacopan Monotherapy in Paroxysmal Nocturnal HemoglobinuriaRégis Peffault de Latour, Alexander Röth, Austin G Kulasekararaj, et al.
Nature Genetics|August 16, 2011
A genome-wide association study identifies two new risk loci for Graves' diseaseXun Chu, Chun-Ming Pan, Shuang-Xia Zhao, et al.
The Lancet. Haematology|May 30, 2025
Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitorsAntonio M Risitano, Austin G Kulasekararaj, Phillip Scheinberg, et al.
Medical Image Analysis|July 7, 2026
Multi-class segmentation of aortic branches and zones in computed tomography angiography: The AortaSeg24 challengeMuhammad Imran, Jonathan R Krebs, Vishal Balaji Sivaraman, et al.
Pageof 251